Article
Covid-19 in end-stage renal disease patients with renal replacement therapies: a systematic review and meta-analysis
2021-01-26
Abstract excerpt
<h4>Introduction</h4> The novel coronavirus (COVID-19), caused by SARS-CoV-2, showed various prevalence and case-fatality rates (CFR) among patients with different pre-existing chronic conditions. End-stage renal disease (ESRD) patients with renal replacement therapy (RRT) might have a higher prevalence and CFR due to reduced immune function from uremia and kidney tropism of SARS-CoV-2, but there was no systematic...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3fa1fd13-bede-5c60-8064-cd26a4dcba3f
- DOI
- 10.1101/2021.01.25.21250454
